pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-378f |
Genomic Coordinates | chr1: 23929070 - 23929147 |
Description | Homo sapiens miR-378f stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-378f | |||||||||||||||||||||
Sequence | 52| ACUGGACUUGGAGCCAGAAG |71 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MYRF | ||||||||||||||||||||
Synonyms | C11orf9, MRF, Ndt80, pqn-47 | ||||||||||||||||||||
Description | myelin regulatory factor | ||||||||||||||||||||
Transcript | NM_001127392 | ||||||||||||||||||||
Other Transcripts | NM_013279 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MYRF | |||||||||||||||||||||
3'UTR of MYRF (miRNA target sites are highlighted) |
>MYRF|NM_001127392|3'UTR 1 GCTGCCCTCCTGAGGCAGCACCACACCAGGGACCAGGGGTGCCCAGGCACCCCCCAACACTGGATGCAATGGTGTTACAC 81 TGGAGCCCGCTGCAGGCCAGCTCTGCTGTTCACTGGCCCTACCCGAGACTGGTGAAACTGGAAGTCTTCACACTGGAGTT 161 GCTGTTCCAGCTGGTCGCCCCTCACGGCACAGAGGGAACCTGAGAGCCAGAGACTTCTTGGGCCTTCCTGCCTGCCACCC 241 CCTAGGGGCCAGGACAGGACCAGTTTACCTCTTTCCAGATATGGTGGTTGGAGGGCTGGTTCAGGTGCCCTGGAGGGAAG 321 GGGAAGCCTGTGGCCCTGATTTGTTCAGAGCCCATTCTCCCTTGCCTCCCCTTTTGAGACTGGAGCCAACCCTTTTGGAG 401 AGAGGACCTGCCCACCTTTGAGATCAGCAGGGGGCTCGGATCCAGCCCTAAGAGACTTGGGTGGACCCCCATGAGTCAAT 481 GGAGGGCAGACGGCTCTCCCCCTTAAAGCTGTTCCCTGGGGGATGGCTTGGTAGTGGACTTTCTGGGGTTTGCCTGTTAC 561 GCCAGACTCGGACTTCTAAGCTTTAAGTGTGGCCCAGGAGGTTTCTTCTCCCTGGGAGGGCTTGGCTCCCAAGAAGTCCC 641 AGGGCAGCCGAGGCCAGCCCTGCCTGGGTTGGAGAAACTGACTTTGTGCCTTAAGTCTACTCAGTGCCTGGTGAAGCCAC 721 CCTCAGCCCTTCACAGGCCTGAACCAGTAGGGGCCAGTGGGCCAGGTAAGCCCTAGAGCCTTGAACCAGGAATATCCAGG 801 AAGAGGAAATTCCCTTTGAGCCCCCAGATGGTATTGCAGCTTCACTGCCTGCGTTCCTGGGAGCGTCTGGAGCTCACAGT 881 GATCAGTGACCACATCATTCTCTCTGAGCAGAGGAGCAGGAATCCCTCAAGCAGCAGCCTGGTCTTGGCTGGTGGGCAGA 961 TGCAAATAGCTTTTGCTGTTATTAATGAAGTAATTACTAAATGCACTTAAACCAGGGCAGGAAGGAATGGAAGGATGGAG 1041 CTAGAAAGCTCAGAGTGGGCCAGAGCAGGGGTGTGACACTTGCAAAGACAGGGCTCTGACTCTGATCCCTCCCAGGGAGC 1121 CTCCGACACCCATCCCACTCCCAACCACCAAGACCCTGGGTTAGGGAAGAAGTTGTATCTTAAGTGCCACCTTCAAGTTT 1201 CTTAGTGGTGCCTGGTGCATTCCGAGGCTACATCCAGGCTCATGGAAGGAGTGTAGTATTCATTTAGCCATGTCTGCCAT 1281 GGGTCCAGAAATGGGAAAGGGAATTGCTGTCCTTGCCCTGTGGTATGCTGCCACCTCTTTGGGAAGCAGGCCTTGCCCCT 1361 GTCCCACCACTCATTCTCAGCTTTGAATGGGAGGCCTTTCTATAGTGGAGGCCTTTCCTTGAAGCCTATGAACTGCAGGC 1441 CCCCTTTTGCCATTGATCTCAAAGCACTTGTCCTCAGGATAGGGAAGAGCAGGGGGATGCAGGAATAGCAGGGATAGCTT 1521 GCTCCCAGCCCCCTCCCCAATTTGGTTCCGTTGACATAGGAATTTTACGATTCCCAAACCATGCAGGGGCTGAGCCTTCC 1601 TTATGATGACTTTGTTCTCCCTCCCACTGGGGGAATCCTCCCTATGCCTTAAAACTGCCGAGCCCCACTCCATGTAATAG 1681 GATTCCTGGGCTTCCTCAATGGGGGTTCATGTTCTTGGACTGCGGGCCCTCAGTCCTTAACTGGAAAGTGACCGTCCACT 1761 GCCCCATGGAGCCCATCTGGACACAGCACAGCCCCAAAACCGTTAGCAGCTGGCTCTGTTTCCAAGCCTGGGGAGGGGTT 1841 CCTCAGTGCAGGAGTTGGGGACAGGCTGGGGATCCAAGCTGCTTGAGGGGGTCAACCTTGGACCAAAGTTGCCTTAAGCC 1921 TGTGGTAAAAGGGCTTCAGGGAAGGTAAGTGGGCCACCTGCTGGAAGCTGCCAGCTGCCCGGCTGGCAATGGTGTGAGTG 2001 TCTTGGCCCTGTCCCTGCCCTGGGGTCCAGCAGGTCATCCCTCCCTTCTTCTCTCTCCTTTGGCGTTTGTTCCTGTAGTC 2081 ACTGGGCTAATCTCCCCCTAGCTTCAAGCTGTACATAGGGCCTCCCAGTGCAAATCCTCCTGCCCATACCGTGCACCCTT 2161 AGAAGCCTGCGTGTGCATAGAGCGCCCCCTACTTCCCAGTTAACTCCCAGTTCTTCTCCCTGAGCTTGGTATTTGTCATG 2241 TGCCAACTCTGACTCTGAGGTGGGCAGTGAGGGAAGCAGCCCCGGGCCTGCTTGCTTCCTGTCCCCGAAATGTTCGTTTC 2321 TTCTGAAGTAAATATACATATATAAATAAATGTATAAATACTGCTTTGTATCTGAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000278836.5 | 3UTR | AAAUGGGAAAGGGAAUUGCUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
27 hsa-miR-378f Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT463100 | ZNF609 | zinc finger protein 609 | 2 | 2 | ||||||||
MIRT469371 | REST | RE1 silencing transcription factor | 2 | 6 | ||||||||
MIRT495441 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | 2 | 2 | ||||||||
MIRT513606 | VPS37B | VPS37B, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT520414 | TXNL1 | thioredoxin like 1 | 2 | 4 | ||||||||
MIRT525111 | PRKD2 | protein kinase D2 | 2 | 2 | ||||||||
MIRT525979 | SPA17 | sperm autoantigenic protein 17 | 2 | 2 | ||||||||
MIRT527002 | ARL8B | ADP ribosylation factor like GTPase 8B | 2 | 2 | ||||||||
MIRT529215 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT529835 | ARGFX | arginine-fifty homeobox | 2 | 2 | ||||||||
MIRT532300 | HAUS3 | HAUS augmin like complex subunit 3 | 2 | 2 | ||||||||
MIRT537577 | ESYT2 | extended synaptotagmin 2 | 2 | 2 | ||||||||
MIRT543140 | AKT1 | AKT serine/threonine kinase 1 | 2 | 2 | ||||||||
MIRT554924 | RAP1B | RAP1B, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT564970 | WTAP | WT1 associated protein | 2 | 2 | ||||||||
MIRT570115 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT652734 | TGFB2 | transforming growth factor beta 2 | 2 | 2 | ||||||||
MIRT655948 | NDST1 | N-deacetylase and N-sulfotransferase 1 | 2 | 2 | ||||||||
MIRT655997 | MYRF | myelin regulatory factor | 2 | 2 | ||||||||
MIRT684875 | P4HB | prolyl 4-hydroxylase subunit beta | 2 | 2 | ||||||||
MIRT692969 | LGSN | lengsin, lens protein with glutamine synthetase domain | 2 | 2 | ||||||||
MIRT693737 | ACACA | acetyl-CoA carboxylase alpha | 2 | 2 | ||||||||
MIRT710991 | PPARGC1B | PPARG coactivator 1 beta | 2 | 2 | ||||||||
MIRT712247 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT718602 | DCTPP1 | dCTP pyrophosphatase 1 | 2 | 2 | ||||||||
MIRT723499 | WDR33 | WD repeat domain 33 | 2 | 2 | ||||||||
MIRT725448 | HIPK3 | homeodomain interacting protein kinase 3 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|